ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2946Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 5,335 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 2.21% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 4,389 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 4.11% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 197,262 shares, the number of shares held increased 1.68% compared to the previous period and now represents 3.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 136,566 shares, the number of shares held decreased 1.13% compared to the previous period and now represents 3.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 26,620 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 1.35% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 17,418 shares, the number of shares held decreased 0.14% compared to the previous period and now represents 3.73% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 17,969 shares, the number of shares held decreased 0.87% compared to the previous period and now represents 2.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 30,348 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 3.5% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 280 shares, the number of shares held increased 1.13% compared to the previous period and now represents 0.98% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 146,410 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 1.44% of the total position.
Go to Tiger App to see more news